Product NDC: | 54738-901 |
Proprietary Name: | Quinidine Gluconate |
Non Proprietary Name: | Quinidine Gluconate |
Active Ingredient(s): | 324 mg/1 & nbsp; Quinidine Gluconate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54738-901 |
Labeler Name: | Richmond Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA089338 |
Marketing Category: | ANDA |
Start Marketing Date: | 19870210 |
Package NDC: | 54738-901-02 |
Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (54738-901-02) |
NDC Code | 54738-901-02 |
Proprietary Name | Quinidine Gluconate |
Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (54738-901-02) |
Product NDC | 54738-901 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Quinidine Gluconate |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19870210 |
Marketing Category Name | ANDA |
Labeler Name | Richmond Pharmaceuticals, Inc. |
Substance Name | QUINIDINE GLUCONATE |
Strength Number | 324 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA] |